Abstract Details

Title The NRF2 transcriptional target, OSGIN1, contributes to the cytoprotective properties of monomethyl fumarate.

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 150

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Melanie Brennan PRESENTER	No disclosure on file
Peter A. LeWitt, MD (Henry Ford Hospital - Franklin Pointe)	Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. LeWitt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ONO Pharmaceuticals. Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. LeWitt has received research support from Michael J Fox Foundation.
	No disclosure on file
	No disclosure on file
	No disclosure on file
Robert H. Scannevin, PhD	No disclosure on file

��ɫ����